Show simple item record

Cladribine Personalised Dosing to Treat Active Multiple Sclerosis - Follow-up in 250 patients

dc.contributor.authorAllen-Philbey, K
dc.contributor.authorDe Trane, S
dc.contributor.authorStennett, A
dc.contributor.authorYildiz, O
dc.contributor.authorAdams, A
dc.contributor.authorTurner, B
dc.contributor.authorMarta, M
dc.contributor.authorGnanapavan, S
dc.contributor.authorBianchi, L
dc.contributor.authorMathews, J
dc.contributor.authorGiovannoni, G
dc.contributor.authorBaker, D
dc.contributor.authorSchmierer, K
dc.date.accessioned2021-07-26T13:29:33Z
dc.date.available2021-07-26T13:29:33Z
dc.date.issued2021-06
dc.identifier.issn1352-4585
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/73240
dc.description.abstractThis is the accepted manuscript of an article published online: 1. ACTRIMS Forum 2021 – Poster Presentations. Multiple Sclerosis Journal. 2021;27(1_suppl):15-122. doi:10.1177/13524585211015908en_US
dc.format.extent90 - 91
dc.titleCladribine Personalised Dosing to Treat Active Multiple Sclerosis - Follow-up in 250 patientsen_US
dc.typeConference Proceedingen_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000669008200190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue1_SUPPLen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume27en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail
Name:
Schmierer P160: Cladribine ...
Size:
15.04Kb
Format:
application/
Description:
Accepted version
View/Open

This item appears in the following Collection(s)

Show simple item record